Dijkgraaf MG - Search Results

1

Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brain.

Rombach SM, Smid BE, Bouwman MG, Linthorst GE, Dijkgraaf MG, Hollak CE. Rombach SM, et al. Among authors: dijkgraaf mg. Orphanet J Rare Dis. 2013 Mar 25;8:47. doi: 10.1186/1750-1172-8-47. Orphanet J Rare Dis. 2013. PMID: 23531228 Free PMC article.

2

Cost-effectiveness of enzyme replacement therapy for Fabry disease.

Rombach SM, Hollak CE, Linthorst GE, Dijkgraaf MG. Rombach SM, et al. Among authors: dijkgraaf mg. Orphanet J Rare Dis. 2013 Feb 19;8:29. doi: 10.1186/1750-1172-8-29. Orphanet J Rare Dis. 2013. PMID: 23421808 Free PMC article.

3

Natural course of Fabry disease and the effectiveness of enzyme replacement therapy: a systematic review and meta-analysis: effectiveness of ERT in different disease stages.

Rombach SM, Smid BE, Linthorst GE, Dijkgraaf MG, Hollak CE. Rombach SM, et al. Among authors: dijkgraaf mg. J Inherit Metab Dis. 2014 May;37(3):341-52. doi: 10.1007/s10545-014-9677-8. Epub 2014 Feb 4. J Inherit Metab Dis. 2014. PMID: 24492980 Review.

4

Cost-effectiveness of enzyme replacement therapy for type 1 Gaucher disease.

van Dussen L, Biegstraaten M, Hollak CE, Dijkgraaf MG. van Dussen L, et al. Among authors: dijkgraaf mg. Orphanet J Rare Dis. 2014 Apr 14;9:51. doi: 10.1186/1750-1172-9-51. Orphanet J Rare Dis. 2014. PMID: 24731506 Free PMC article.

5

Modelling Gaucher disease progression: long-term enzyme replacement therapy reduces the incidence of splenectomy and bone complications.

van Dussen L, Biegstraaten M, Dijkgraaf MG, Hollak CE. van Dussen L, et al. Among authors: dijkgraaf mg. Orphanet J Rare Dis. 2014 Jul 24;9:112. doi: 10.1186/s13023-014-0112-x. Orphanet J Rare Dis. 2014. PMID: 25056340 Free PMC article.

6

Predictors of objective cognitive impairment and subjective cognitive complaints in patients with Fabry disease.

Körver S, Geurtsen GJ, Hollak CEM, van Schaik IN, Longo MGF, Lima MR, Vedolin L, Dijkgraaf MGW, Langeveld M. Körver S, et al. Sci Rep. 2019 Jan 17;9(1):188. doi: 10.1038/s41598-018-37320-0. Sci Rep. 2019. PMID: 30655570 Free PMC article.

7

Disease progression in women with X-linked adrenoleukodystrophy is slow.

Huffnagel IC, Dijkgraaf MGW, Janssens GE, van Weeghel M, van Geel BM, Poll-The BT, Kemp S, Engelen M. Huffnagel IC, et al. Orphanet J Rare Dis. 2019 Feb 7;14(1):30. doi: 10.1186/s13023-019-1008-6. Orphanet J Rare Dis. 2019. PMID: 30732635 Free PMC article.

8

Depressive symptoms in Fabry disease: the importance of coping, subjective health perception and pain.

Körver S, Geurtsen GJ, Hollak CEM, van Schaik IN, Longo MGF, Lima MR, Vedolin L, Dijkgraaf MGW, Langeveld M. Körver S, et al. Orphanet J Rare Dis. 2020 Jan 28;15(1):28. doi: 10.1186/s13023-020-1307-y. Orphanet J Rare Dis. 2020. PMID: 31992347 Free PMC article.

9

Determinants of cerebral radiological progression in Fabry disease.

Körver S, Longo MGF, Lima MR, Hollak CEM, El Sayed M, van Schaik IN, Vedolin L, Dijkgraaf MGW, Langeveld M. Körver S, et al. J Neurol Neurosurg Psychiatry. 2020 Jul;91(7):756-763. doi: 10.1136/jnnp-2019-322268. Epub 2020 Apr 21. J Neurol Neurosurg Psychiatry. 2020. PMID: 32317398 Free article.

10

Cognitive functioning and depressive symptoms in Fabry disease: A follow-up study.

Körver S, Geurtsen GJ, Hollak CEM, van Schaik IN, Longo MGF, Lima MR, Dijkgraaf MGW, Langeveld M. Körver S, et al. J Inherit Metab Dis. 2020 Sep;43(5):1070-1081. doi: 10.1002/jimd.12271. Epub 2020 Jun 25. J Inherit Metab Dis. 2020. PMID: 32510623 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

400 results

Search Page